MSA
BSX icon

Marino Stram & Associates’s Boston Scientific BSX Stock Holding History

Marino Stram & Associates’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-300
Closed -$12K – 144
2019
Q1 		$12K Hold
300
– – 0.01% 290
2018
Q4 		$11K Sell
300
-800
-73% -$29K 0.01% 265
2018
Q3 		$42K Hold
1,100
– – 0.03% 182
2018
Q2 		$36K Hold
1,100
– – 0.03% 190
2018
Q1 		$30K Hold
1,100
– – 0.03% 208
2017
Q4 		$27K Buy
+1,100
New +$30.3K 0.02% 218

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Marino Stram & Associates's BSX Position: Q2 2019 in Review

Marino Stram & Associates sold out of Boston Scientific (BSX) in Q2 2019, closing a stake of 300 shares — an estimated $12K sold.

Marino Stram & Associates first reported a position in BSX in Q4 2017 and held it in 6 quarters. The position peaked at $42K in Q3 2018. 757 funds tracked by Wall St. Rank hold BSX as of Q2 2019.

  • Marino Stram & Associates reported no remaining Boston Scientific position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 300 Boston Scientific shares in Q2 2019, an estimated $12K.
  • Marino Stram & Associates first reported a position in Boston Scientific in Q4 2017 and held it in 6 quarters.
  • Marino Stram & Associates's Boston Scientific position peaked at $42K in Q3 2018.
  • 757 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.